Los Angeles, CA -- (SBWIRE) -- 06/24/2019 -- Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.
The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.
The global Human Chorionic Gonadotropin (HCG) market was 390 million US$ in 2018 and is expected to 620 million US$ by the end of 2025, growing at a CAGR of 6.0% between 2019 and 2025.
Get a sample PDF of the report at https://www.qyresearch.com/sample-form/form/1141489/global-human-chorionic-gonadotropin-hcg-market
This report studies the Human Chorionic Gonadotropin (HCG) market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Human Chorionic Gonadotropin (HCG) in these regions, from 2014 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
By the product type, the market is primarily split into
Natural Source Extraction
Recombinant DNA Technology
By the end users/application, this report covers the following segments
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
Get Full Report Now at USD 3,350:
https://www.qyresearch.com/settlement/pre/8cb70804ed013a7ff46283e56ea2e901,0,1,Global%20Human%20Chorionic%20Gonadotropin%20(HCG)%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application
About QYResearch
QYResearch established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. the company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc industries experts who own more than 10 years experiences on marketing or R&D), professional survey team (the team member with more than 3 years market survey experience and more than 2 years depth expert interview experience). Excellent data analysis team (SPSS statistics and PPT graphics process team).